Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 8-K __________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2021 __________________ DANAHER CORPORATION (Exact Name of Registrant as Specified in Its Charter) __________________ Delaware 001-08089 59-1995548 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 2200 Pennsylvania Avenue, NW 20037-1701 Suite 800W Washington, DC (Address of Principal Executive Offices)   (Zip Code) 202 - 828-0850 (Registrant’s Telephone Number, Including Area Code) Not applicable (Former Name or Former Address, if Changed Since Last Report) __________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below) : ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.01 par value DHR New York Stock Exchange 4.75% Mandatory Convertible Preferred Stock, Series A, without par value DHR.PRA New York Stock Exchange 5.00% Mandatory Convertible Preferred Stock, Series B, without par value DHR.PRB New York Stock Exchange Floating Rate Senior Notes due 2022 DHR/22A New York Stock Exchange 1.700% Senior Notes due 2024 DHR 24 New York Stock Exchange 2.500% Senior Notes due 2025 DHR/25 New York Stock Exchange 0.200% Senior Notes due 2026 DHR/26 New York Stock Exchange 2.100% Senior Notes due 2026 DHR 26 New York Stock Exchange 1.200% Senior Notes due 2027 DHR/27 New York Stock Exchange 0.450% Senior Notes due 2028 DHR/28 New York Stock Exchange 2.500% Senior Notes due 2030 DHR 30 New York Stock Exchange 0.750% Senior Notes due 2031 DHR/31 New York Stock Exchange 1.350% Senior Notes due 2039 DHR/39 New York Stock Exchange 1.800% Senior Notes due 2049 DHR/49 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS     The Company’s annual meeting of shareholders was held on May 5, 2021. At the annual meeting, the Company’s shareholders voted on the following proposals: 1.    To elect the twelve directors named in the Company’s proxy statement to terms expiring in 2022. Each nominee for director was elected by a vote of the shareholders as follows: For Against Abstain Broker Non-Votes Rainer M. Blair 598,332,314  6,849,314  263,929  31,854,513  Linda Hefner Filler 566,294,780  38,891,682  259,095  31,854,513  Teri List 474,167,539  129,982,320  1,295,698  31,854,513  Walter G. Lohr, Jr. 450,506,870  153,651,351  1,287,336  31,854,513  Jessica L. Mega, MD, MPH 602,716,721  2,467,616  261,220  31,854,513  Mitchell P. Rales 576,534,187  28,639,182  272,188  31,854,513  Steven M. Rales 581,752,039  23,283,781  409,737  31,854,513  Pardis C. Sabeti, MD, D. Phil 602,723,264  2,446,107  276,186  31,854,513  John T. Schwieters 445,222,109  158,938,378  1,285,070  31,854,513  Alan G. Spoon 561,261,023  43,904,007  280,527  31,854,513  Raymond C. Stevens, PhD 602,691,918  2,462,313  291,326  31,854,513  Elias A. Zerhouni, MD 588,152,890  17,009,195  283,472  31,854,513  2.    To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021. The proposal was approved by a vote of shareholders as follows: For 627,756,529  Against 8,954,071  Abstain 589,470  3.    To approve on an advisory basis the Company’s named executive officer compensation. The proposal was approved by a vote of shareholders as follows: For 575,840,385  Against 28,142,256  Abstain 1,462,916  Broker Non-Votes 31,854,513  4.    To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%. The proposal was rejected by a vote of shareholders as follows: For 252,403,505  Against 348,720,913  Abstain 4,321,139  Broker Non-Votes 31,854,513  ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits: Exhibit No.    Description 104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DANAHER CORPORATION Date: May 7, 2021 By:      /s/ James F. O'Reilly James F. O'Reilly Vice President, Deputy General Counsel and Secretary